Mounjaro beats Ozempic for weight loss in early trial
The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report.
Nov 29, 2023
0
4
The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report.
Nov 29, 2023
0
4
A study from King's College London, which is published on the pre-print server MedRxiv and has not been peer-reviewed, shows that while two thirds of individuals with post-COVID illness were healthy before infection, individuals ...
Nov 7, 2023
0
17
Being taller during the course of a person's lifetime could protect against heart disease and stroke in later life, according to a new University of Bristol-led study. The research, which analyzed height and genetic data ...
Nov 3, 2023
0
0
Every year, around 10 million people contract tuberculosis (TB)—a treatable disease where bacteria attack a patient's lungs. Globally, only about half of those who contract TB yearly are diagnosed. Many other people with ...
Nov 3, 2023
0
0
University of Queensland researchers have shown that endometriosis and irritable bowel syndrome (IBS) share genetic risk factors, explaining why patients with one condition may also have the other.
Oct 26, 2023
0
39
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the antidepressant fluvoxamine at a dosage of 100 mg twice daily for ...
Sep 14, 2023
0
0
COVID patients exhale high numbers of virus during the first eight days after symptoms start, as high as 1,000 copies per minute, reports a new Northwestern Medicine study.
Sep 11, 2023
1
3
A team of researchers, including Te Whare Wānanga o Waitaha | University of Canterbury (UC) Dr. Leighton Watson and Professor Michael Plank, combined wastewater data with reported case numbers to create a statistical model ...
Aug 21, 2023
0
1
The lone volunteer in a gene-editing study targeting a rare form of Duchenne muscular dystrophy likely died after having a reaction to the virus that delivered the therapy in his body, researchers concluded in an early study.
Jun 1, 2023
0
38
With the FDA authorizing a second bivalent booster this week for individuals at high risk from COVID-19 and the CDC expected to sign off on it as well, a recent Houston Methodist study may offer some guidance on when certain ...
Apr 19, 2023
0
6